Synthesis and immunological evaluation of TLR1/2 ligand-conjugated RBDs as self-adjuvanting vaccine candidates against SARS-CoV-2

Yoshiyuki Manabe, Brandon Gárate-Reyes, Keita Ito, Ramón Hurtado-Guerrero, Kazuya Kabayama and Koichi Fukase

Chem. Commun., 2024, 60, 3946
DOI: 10.1039/D4CC00462K

A protein vaccine with Alum/c-GAMP/poly(I:C) rapidly boosts robust immunity against SARS-CoV-2 and variants of concern

Ru-Yan Zhang, Xu-Guang Yin, Shi-Hao Zhou, Hai-Wei Zhang, Jie Lu, Chen-Bin He, Jian Wang, Yu Wen, Yu-Ting Li, Yan-Ling Liu, Ran-Ran Feng, Dong Ding, Hua-Wei Wei, Rui Gong, Guang-Fu Yang and Jun Guo

Chem. Commun., 2022, 58, 3925
DOI: 10.1039/D2CC00271J

Synthetic vaccines targeting Mincle through conjugation of trehalose dibehenate

Cameron C. Hanna, Joshua W. C. Maxwell, Hendra S. Ismanto, Anneliese S. Ashhurst, Lukas M. Artner, Santosh Rudrawar, Warwick J. Britton, Sho Yamasaki and Richard J. Payne

Chem. Commun., 2022, 58, 6890
DOI: 10.1039/D2CC02100E

Role of toll‐like receptors in the pathogenesis of COVID‐19: Current and future perspectives

Ming‐Yan Yang, Mei‐Hua Zheng, Xiang‐Ting Meng, Le‐Wei Ma, Hai‐Yue Liang and Hua‐Ying Fan

Scand J Immunol, 2023, 98
DOI: 10.1111/sji.13275

Multifunctional Lipidated Protein Carrier with a Built-In Adjuvant as a Universal Vaccine Platform Potently Elevates Immunogenicity of Weak Antigens

Shi-Hao Zhou, Ru-Yan Zhang, Yu Wen, Yong-Ke Zou, Dong Ding, Miao-Miao Bian, Hong-Ying Cui and Jun Guo

J. Med. Chem., 2024, 67, 6822
DOI: 10.1021/acs.jmedchem.4c00412

Alum Adjuvant and Built-in TLR7 Agonist Synergistically Enhance Anti-MUC1 Immune Responses for Cancer Vaccine

Shi-Hao Zhou, Yu-Ting Li, Ru-Yan Zhang, Yan-Ling Liu, Zi-Wei You, Miao-Miao Bian, Yu Wen, Jian Wang, Jing-Jing Du and Jun Guo

Front. Immunol., 2022, 13
DOI: 10.3389/fimmu.2022.857779

Conjugation of TLR7 and TLR7/8 agonists onto weak protein antigen via versatile oxime ligation for enhanced vaccine efficacy

Ru-Yan Zhang, Yu Wen, Chen-Bin He, Shi-Hao Zhou, Ye-Hui Wu, En-Yang Wang, Ran-Ran Feng, Dong Ding, Jing-Jing Du, Xiao-Fei Gao and Jun Guo

International Journal of Biological Macromolecules, 2024, 278, 134620
DOI: 10.1016/j.ijbiomac.2024.134620

MUC1 Specific Immune Responses Enhanced by Coadministration of Liposomal DDA/MPLA and Lipoglycopeptide

Jing-Jing Du, Shi-Hao Zhou, Zi-Ru Cheng, Wen-Bo Xu, Ru-Yan Zhang, Long-Sheng Wang and Jun Guo

Front. Chem., 2022, 10
DOI: 10.3389/fchem.2022.814880

A Perspective on the Roles of Adjuvants in Developing Highly Potent COVID-19 Vaccines

Naru Zhang, Kangchen Li, Zezhong Liu, Kutty Selva Nandakumar and Shibo Jiang

Viruses, 2022, 14, 387
DOI: 10.3390/v14020387

Adjuvant-Protein Conjugate Vaccine with Built-In TLR7 Agonist on S1 Induces Potent Immunity against SARS-CoV-2 and Variants of Concern

Ru-Yan Zhang, Shi-Hao Zhou, Chen-Bin He, Jian Wang, Yu Wen, Ran-Ran Feng, Xu-Guang Yin, Guang-Fu Yang and Jun Guo

ACS Infect. Dis., 2022, 8, 1367
DOI: 10.1021/acsinfecdis.2c00259

pH-Sensitive and Biodegradable Mn3(PO4)2·3H2O Nanoparticles as an Adjuvant of Protein-Based Bivalent COVID-19 Vaccine to Induce Potent and Broad-Spectrum Immunity

Shi-Hao Zhou, Ru-Yan Zhang, Zi-Wei You, Yong-Ke Zou, Yu Wen, Jian Wang, Dong Ding, Miao-Miao Bian, Zhi-Ming Zhang, Hong Yuan, Guang-Fu Yang and Jun Guo

ACS Appl. Mater. Interfaces, 2023, 15, 8914
DOI: 10.1021/acsami.2c19736

SARS-CoV-2 conjugate vaccine elicits robust immune responses that can protect against evolving variants.

Melanie Carroll, Heather B. Fox, Anh Tran, Gowri Chellappan, Leonardo V. Rojas, Geetha Karengil, Fataneh Karandish, John W. Langston, Brent M. Fall, Mary M. Whalen, Michael J. McCluskie, Yves Durocher, Anup Datta, Subhash V. Kapre and Ivan A. Olave

Vaccine, 2025, 54, 126988
DOI: 10.1016/j.vaccine.2025.126988

Role of toll-like receptors in post-COVID-19 associated neurodegenerative disorders?

Senthil Kumaran Satyanarayanan, Tsz Fung Yip, Zixu Han, Huachen Zhu, Dajiang Qin and Suki Man Yan Lee

Front. Med., 2025, 12
DOI: 10.3389/fmed.2025.1458281

Cellular Sensors and Viral Countermeasures: A Molecular Arms Race between Host and SARS-CoV-2

Haoran Sun, Jasper Fuk-Woo Chan and Shuofeng Yuan

Viruses, 2023, 15, 352
DOI: 10.3390/v15020352

Polymer modification of SARS-CoV-2 spike protein impacts its ability to bind key receptor

Monica Sharfin Rahman, Nethmi De Alwis Watuthanthrige, Bhagya M. Chandrarathne, Richard C. Page and Dominik Konkolewicz

European Polymer Journal, 2023, 184, 111767
DOI: 10.1016/j.eurpolymj.2022.111767

Recent advances in chemical protein synthesis: method developments and biological applications

Suwei Dong, Ji-Shen Zheng, Yiming Li, Huan Wang, Gong Chen, Yongxiang Chen, Gemin Fang, Jun Guo, Chunmao He, Honggang Hu, Xuechen Li, Yanmei Li, Zigang Li, Man Pan, Shan Tang, Changlin Tian, Ping Wang, Bian Wu, Chuanliu Wu, Junfeng Zhao and Lei Liu

Sci. China Chem., 2024, 67, 1060
DOI: 10.1007/s11426-024-1950-1

Pattern Recognition Receptors (PRRs) Expression and Activation in COVID-19 and Long COVID: From SARS-CoV-2 Escape Mechanisms to Emerging PRR-Targeted Immunotherapies

Luca Maddaloni, Ginevra Bugani, Matteo Fracella, Camilla Bitossi, Alessandra D’Auria, Francesca Aloisi, Abir Azri, Letizia Santinelli, Manel Ben M’Hadheb, Alessandra Pierangeli, Federica Frasca and Carolina Scagnolari

Microorganisms, 2025, 13, 2176
DOI: 10.3390/microorganisms13092176

Adjuvant-Free COVID-19 Vaccine with Glycoprotein Antigen Oxidized by Periodate Rapidly Elicits Potent Immune Responses

Ru-Yan Zhang, Shi-Hao Zhou, Ran-Ran Feng, Yu Wen, Dong Ding, Zhi-Ming Zhang, Hua-Wei Wei and Jun Guo

ACS Chem. Biol., 2023, 18, 915
DOI: 10.1021/acschembio.3c00050

Toll-like receptor (TLRs) agonists and antagonists for COVID-19 treatments

Zhi-Mei Liu, Ming-Hui Yang, Kun Yu, Zheng-Xing Lian and Shou-Long Deng

Front. Pharmacol., 2022, 13
DOI: 10.3389/fphar.2022.989664

Novel sialoglycan linkage for constructing adjuvant-protein conjugate as potent vaccine for COVID-19

Yu Wen, Ru-Yan Zhang, Jian Wang, Shi-Hao Zhou, Xiao-Qian Peng, Dong Ding, Zhi-Ming Zhang, Hua-Wei Wei and Jun Guo

Journal of Controlled Release, 2023, 355, 238
DOI: 10.1016/j.jconrel.2023.01.062

MPLA-Adjuvanted Liposomes Encapsulating S-Trimer or RBD or S1, but Not S-ECD, Elicit Robust Neutralization Against SARS-CoV-2 and Variants of Concern

Jian Wang, Xu-Guang Yin, Yu Wen, Jie Lu, Ru-Yan Zhang, Shi-Hao Zhou, Chun-Miao Liao, Hua-Wei Wei and Jun Guo

J. Med. Chem., 2022, 65, 3563
DOI: 10.1021/acs.jmedchem.1c02025

COVID‐19: Clinical status of vaccine development to date

Sunny Kumar, Malini Basu, Pratyasha Ghosh, Aafreen Ansari and Mrinal K. Ghosh

Brit J Clinical Pharma, 2023, 89, 114
DOI: 10.1111/bcp.15552

Self-Adjuvanting Protein Vaccine Conjugated with a Novel Synthetic TLR4 Agonist on Virus-Like Liposome Induces Potent Immunity against SARS-CoV-2

Dong Ding, Yu Wen, Chun-Miao Liao, Xu-Guang Yin, Ru-Yan Zhang, Jian Wang, Shi-Hao Zhou, Zhi-Ming Zhang, Yong-Ke Zou, Xiao-Fei Gao, Hua-Wei Wei, Guang-Fu Yang and Jun Guo

J. Med. Chem., 2023, 66, 1467
DOI: 10.1021/acs.jmedchem.2c01642